CBT vs. LYB: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at CBT and LYB, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | CBT | LYB |
|---|---|---|
| Company Name | Cabot Corporation | LyondellBasell Industries N.V. |
| Country | United States | United States |
| GICS Sector | Materials | Materials |
| GICS Industry | Chemicals | Chemicals |
| Market Capitalization | 4.37 billion USD | 17.02 billion USD |
| Exchange | NYSE | NYSE |
| Listing Date | November 5, 1980 | April 28, 2010 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of CBT and LYB by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | CBT | LYB |
|---|---|---|
| 5-Day Price Return | 5.54% | 5.50% |
| 13-Week Price Return | 7.80% | -12.77% |
| 26-Week Price Return | -6.63% | -31.92% |
| 52-Week Price Return | -13.84% | -44.71% |
| Month-to-Date Return | 13.67% | -8.63% |
| Year-to-Date Return | -10.14% | -28.73% |
| 10-Day Avg. Volume | 0.50M | 7.00M |
| 3-Month Avg. Volume | 0.43M | 4.59M |
| 3-Month Volatility | 32.98% | 48.45% |
| Beta | 0.92 | 0.93 |
Profitability
Return on Equity (TTM)
CBT
29.52%
Chemicals Industry
- Max
- 26.17%
- Q3
- 13.48%
- Median
- 8.13%
- Q1
- 2.52%
- Min
- -11.86%
CBT’s Return on Equity of 29.52% is exceptionally high, placing it well beyond the typical range for the Chemicals industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
LYB
2.08%
Chemicals Industry
- Max
- 26.17%
- Q3
- 13.48%
- Median
- 8.13%
- Q1
- 2.52%
- Min
- -11.86%
LYB’s Return on Equity of 2.08% is in the lower quartile for the Chemicals industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.
Net Profit Margin (TTM)
CBT
11.14%
Chemicals Industry
- Max
- 21.80%
- Q3
- 9.57%
- Median
- 4.44%
- Q1
- 1.14%
- Min
- -11.30%
A Net Profit Margin of 11.14% places CBT in the upper quartile for the Chemicals industry, signifying strong profitability and more effective cost management than most of its peers.
LYB
0.75%
Chemicals Industry
- Max
- 21.80%
- Q3
- 9.57%
- Median
- 4.44%
- Q1
- 1.14%
- Min
- -11.30%
Falling into the lower quartile for the Chemicals industry, LYB’s Net Profit Margin of 0.75% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.
Operating Profit Margin (TTM)
CBT
16.62%
Chemicals Industry
- Max
- 27.33%
- Q3
- 13.97%
- Median
- 8.08%
- Q1
- 4.46%
- Min
- -8.10%
An Operating Profit Margin of 16.62% places CBT in the upper quartile for the Chemicals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
LYB
1.52%
Chemicals Industry
- Max
- 27.33%
- Q3
- 13.97%
- Median
- 8.08%
- Q1
- 4.46%
- Min
- -8.10%
LYB’s Operating Profit Margin of 1.52% is in the lower quartile for the Chemicals industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.
Profitability at a Glance
| Symbol | CBT | LYB |
|---|---|---|
| Return on Equity (TTM) | 29.52% | 2.08% |
| Return on Assets (TTM) | 11.33% | 0.73% |
| Net Profit Margin (TTM) | 11.14% | 0.75% |
| Operating Profit Margin (TTM) | 16.62% | 1.52% |
| Gross Profit Margin (TTM) | 25.16% | 9.47% |
Financial Strength
Current Ratio (MRQ)
CBT
2.13
Chemicals Industry
- Max
- 3.38
- Q3
- 2.23
- Median
- 1.73
- Q1
- 1.39
- Min
- 0.55
CBT’s Current Ratio of 2.13 aligns with the median group of the Chemicals industry, indicating that its short-term liquidity is in line with its sector peers.
LYB
1.77
Chemicals Industry
- Max
- 3.38
- Q3
- 2.23
- Median
- 1.73
- Q1
- 1.39
- Min
- 0.55
LYB’s Current Ratio of 1.77 aligns with the median group of the Chemicals industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
CBT
0.79
Chemicals Industry
- Max
- 1.65
- Q3
- 0.94
- Median
- 0.65
- Q1
- 0.41
- Min
- 0.00
CBT’s Debt-to-Equity Ratio of 0.79 is typical for the Chemicals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
LYB
0.99
Chemicals Industry
- Max
- 1.65
- Q3
- 0.94
- Median
- 0.65
- Q1
- 0.41
- Min
- 0.00
LYB’s leverage is in the upper quartile of the Chemicals industry, with a Debt-to-Equity Ratio of 0.99. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
Interest Coverage Ratio (TTM)
CBT
11.80
Chemicals Industry
- Max
- 56.43
- Q3
- 26.33
- Median
- 9.38
- Q1
- 3.10
- Min
- -9.39
CBT’s Interest Coverage Ratio of 11.80 is positioned comfortably within the norm for the Chemicals industry, indicating a standard and healthy capacity to cover its interest payments.
LYB
3.85
Chemicals Industry
- Max
- 56.43
- Q3
- 26.33
- Median
- 9.38
- Q1
- 3.10
- Min
- -9.39
LYB’s Interest Coverage Ratio of 3.85 is positioned comfortably within the norm for the Chemicals industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | CBT | LYB |
|---|---|---|
| Current Ratio (MRQ) | 2.13 | 1.77 |
| Quick Ratio (MRQ) | 1.25 | 0.92 |
| Debt-to-Equity Ratio (MRQ) | 0.79 | 0.99 |
| Interest Coverage Ratio (TTM) | 11.80 | 3.85 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
CBT
2.25%
Chemicals Industry
- Max
- 6.56%
- Q3
- 4.04%
- Median
- 2.47%
- Q1
- 1.45%
- Min
- 0.00%
CBT’s Dividend Yield of 2.25% is consistent with its peers in the Chemicals industry, providing a dividend return that is standard for its sector.
LYB
10.84%
Chemicals Industry
- Max
- 6.56%
- Q3
- 4.04%
- Median
- 2.47%
- Q1
- 1.45%
- Min
- 0.00%
LYB’s Dividend Yield of 10.84% is exceptionally high, placing it well above the typical range for the Chemicals industry. While this may seem attractive, an unusually high yield can sometimes be a warning sign, reflecting a falling stock price or market concerns about the dividend’s sustainability.
Dividend Payout Ratio (TTM)
CBT
22.35%
Chemicals Industry
- Max
- 181.25%
- Q3
- 95.01%
- Median
- 53.52%
- Q1
- 26.59%
- Min
- 0.00%
CBT’s Dividend Payout Ratio of 22.35% is in the lower quartile for the Chemicals industry. This suggests a conservative dividend policy, with a strategic focus on reinvesting profits for future growth.
LYB
152.02%
Chemicals Industry
- Max
- 181.25%
- Q3
- 95.01%
- Median
- 53.52%
- Q1
- 26.59%
- Min
- 0.00%
LYB’s Dividend Payout Ratio of 152.02% is in the upper quartile for the Chemicals industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.
Dividend at a Glance
| Symbol | CBT | LYB |
|---|---|---|
| Dividend Yield (TTM) | 2.25% | 10.84% |
| Dividend Payout Ratio (TTM) | 22.35% | 152.02% |
Valuation
Price-to-Earnings Ratio (TTM)
CBT
9.92
Chemicals Industry
- Max
- 42.94
- Q3
- 29.77
- Median
- 20.37
- Q1
- 14.27
- Min
- 6.19
In the lower quartile for the Chemicals industry, CBT’s P/E Ratio of 9.92 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
LYB
61.71
Chemicals Industry
- Max
- 42.94
- Q3
- 29.77
- Median
- 20.37
- Q1
- 14.27
- Min
- 6.19
At 61.71, LYB’s P/E Ratio is exceptionally high, exceeding the typical maximum for the Chemicals industry. This suggests the stock may be significantly overvalued compared to its peers and implies high market expectations that could be difficult to meet.
Price-to-Sales Ratio (TTM)
CBT
1.10
Chemicals Industry
- Max
- 4.36
- Q3
- 2.23
- Median
- 1.01
- Q1
- 0.55
- Min
- 0.16
CBT’s P/S Ratio of 1.10 aligns with the market consensus for the Chemicals industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
LYB
0.46
Chemicals Industry
- Max
- 4.36
- Q3
- 2.23
- Median
- 1.01
- Q1
- 0.55
- Min
- 0.16
In the lower quartile for the Chemicals industry, LYB’s P/S Ratio of 0.46 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
Price-to-Book Ratio (MRQ)
CBT
2.61
Chemicals Industry
- Max
- 4.92
- Q3
- 2.56
- Median
- 1.54
- Q1
- 0.97
- Min
- 0.30
CBT’s P/B Ratio of 2.61 is in the upper tier for the Chemicals industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
LYB
1.56
Chemicals Industry
- Max
- 4.92
- Q3
- 2.56
- Median
- 1.54
- Q1
- 0.97
- Min
- 0.30
LYB’s P/B Ratio of 1.56 is within the conventional range for the Chemicals industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | CBT | LYB |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 9.92 | 61.71 |
| Price-to-Sales Ratio (TTM) | 1.10 | 0.46 |
| Price-to-Book Ratio (MRQ) | 2.61 | 1.56 |
| Price-to-Free Cash Flow Ratio (TTM) | 12.11 | 6.27 |